Tags : MAP Report

23andMe’s MAP Report Receives FDA’s 510(k) Clearance for Hereditary Colorectal

  Shots: MAP Report is a direct-to-consumer genetic test and has received FDA approval for MUTYH-associated polyposis (MAP), a hereditary colorectal cancer syndrome Post-FDA approval for BRCA1/BRCA2 (Selected Variants) Genetic Health Risk report in Mar 2018, 23andMe has received its second FDA approval for MAP Report detecting two variants in people with MAP The approval […]Read More